Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel
Journal cover image

Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency.

Publication ,  Journal Article
Masoud, SJ; Saxton, AT; Lidsky, ME; Martin, AN; Herbert, GS; Blazer, DG; Allen, PJ; Cerullo, M
Published in: Ann Surg Oncol
November 2024

BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) price transparency rule tries to facilitate cost-conscious decision-making. For surgical services, such as pancreaticoduodenectomy (PD), factors mediating transparency and real-world reimbursement are not well described. METHODS: The Leapfrog Survey was used to identify United States hospitals performing PD. Financial and operational data were obtained from Turquoise Health and CMS Cost Reports. Chi-square tests and modified Poisson regression evaluated associations with reimbursement disclosure. Two-part logistic and gamma regression models estimated effects of hospital factors on commercial, Medicare, and self-pay reimbursements for PD. RESULTS: Of 452 Leapfrog hospitals, 295 (65%) disclosed PD hospital or procedure reimbursements. Disclosing hospitals were larger (beds > 200: 81.0% vs. 71.3%, p = 0.04), reported higher net margins (0.7% vs. - 2.1%, p = 0.04), more likely for-profit (26.1% vs. 6.4%, p < 0.001), and teaching-affiliated (82.0% vs. 65.6%, p < 0.001). Nonprofit status conferred hospitalization reimbursement increases of $8683-$12,329, while moderate market concentration predicted savings up to $5066. Teaching affiliation conferred reimbursement increases of $4589-$16,393 for hospitalizations and $644 for procedures. Top Leapfrog volume ratings predicted an increase of up to $7795 for only Medicare hospitalization reimbursement. CONCLUSIONS: Nondisclosure of hospital and procedural reimbursements for PD remains a major issue. Transparency was noted in hospitals with higher margins, size, and academic affiliation. Factors associated with higher reimbursement were non-profit status, academic affiliation, and more equitable market share. Reimbursement inconsistently tracked with PD quality or volume measures. Policy changes may be required to incentivize reimbursement disclosure and translate transparency into increased value for patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

November 2024

Volume

31

Issue

12

Start / End Page

8287 / 8297

Location

United States

Related Subject Headings

  • United States
  • Reimbursement Mechanisms
  • Quality of Health Care
  • Pancreaticoduodenectomy
  • Oncology & Carcinogenesis
  • Medicare
  • Insurance, Health, Reimbursement
  • Humans
  • Disclosure
  • Centers for Medicare and Medicaid Services, U.S.
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Masoud, S. J., Saxton, A. T., Lidsky, M. E., Martin, A. N., Herbert, G. S., Blazer, D. G., … Cerullo, M. (2024). Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency. Ann Surg Oncol, 31(12), 8287–8297. https://doi.org/10.1245/s10434-024-15877-7
Masoud, Sabran J., Anthony T. Saxton, Michael E. Lidsky, Allison N. Martin, Garth S. Herbert, Dan G. Blazer, Peter J. Allen, and Marcelo Cerullo. “Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency.Ann Surg Oncol 31, no. 12 (November 2024): 8287–97. https://doi.org/10.1245/s10434-024-15877-7.
Masoud SJ, Saxton AT, Lidsky ME, Martin AN, Herbert GS, Blazer DG, et al. Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency. Ann Surg Oncol. 2024 Nov;31(12):8287–97.
Masoud, Sabran J., et al. “Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency.Ann Surg Oncol, vol. 31, no. 12, Nov. 2024, pp. 8287–97. Pubmed, doi:10.1245/s10434-024-15877-7.
Masoud SJ, Saxton AT, Lidsky ME, Martin AN, Herbert GS, Blazer DG, Allen PJ, Cerullo M. Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency. Ann Surg Oncol. 2024 Nov;31(12):8287–8297.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

November 2024

Volume

31

Issue

12

Start / End Page

8287 / 8297

Location

United States

Related Subject Headings

  • United States
  • Reimbursement Mechanisms
  • Quality of Health Care
  • Pancreaticoduodenectomy
  • Oncology & Carcinogenesis
  • Medicare
  • Insurance, Health, Reimbursement
  • Humans
  • Disclosure
  • Centers for Medicare and Medicaid Services, U.S.